@HeatBiologics "The elderly & those...suffering most...from this pandemic should know they do not need to settle for a 1-size-fits-all solution. We are working to bring...vaccine options to help those at greatest risk." CEO Jeff Wolf on the need for a "super-vaccine": http://bit.ly/2NRvlV3
#ICYMI, Jeff Wolf's thoughts on #COVID-19: "While Congress and the Administration weigh a new funding package to respond to COVID-19, they should keep in mind the special needs of America’s seniors and other immune-compromised high-risk communities": http://bit.ly/2NRvlV3
• Multiple grants received to utilize gp96 platform for various infectious diseases - National Institute of Health (NIH) - Department of Defense (DoD) - Florida Department of Health • Heat Biologics leverages the body Key Differentiation of gp96 Platform:
NO ANTI-VECTOR IMMUNITY ? NO VIRAL ACTIVATION ? NO INTEGRATION OF FOREIGN DNA ? INTO HOST GENOME ? ACTIVATION OF T CELLS ? ACTIVATION OF B CELLS ? HIGH IMMUNOGENICITY ? INDUCTION OF MUCOSAL IMMUNITY ? LONG-TERM MEMORY RESPONSE ?
• Leverages our proprietary gp96 platform to effectively deliver multiple SARS-CoV-2 antigens to activate the immune system. • Designed to elicit long-lasting immune response against SARS-CoV-2 virus • We plan to collaborate with companies, researchers, government agencies and funding organizations to accelerate our COVID-19 vaccine program.
-------------------------------------------------------------------- Heat Biologics Reports Progress on COVID-19 Efforts and Timeline of Anticipated Q2 2020 Milestones:
Market Data 
Markets 
AI
